Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans. - De Sousa-Coelho AL; Rodriguez-Rodriguez R; Softic S; Jonker JW; Relat J (Frontiers in endocrinology, 2023)